PubRank

Hazel M Dockrell

Author PubWeight™ 69.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 2002 3.75
2 Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. J Infect Dis 2006 2.68
3 Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Engl J Med 2014 2.12
4 Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med 2013 1.91
5 Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations. PLoS Med 2008 1.91
6 Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J Infect Dis 2012 1.69
7 Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa. Clin Vaccine Immunol 2009 1.67
8 Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis. PLoS One 2009 1.56
9 Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy. J Infect Dis 2009 1.52
10 Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. J Immunol Methods 2002 1.47
11 Increased Interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis. J Infect Dis 2004 1.45
12 Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination. Infect Immun 2007 1.33
13 Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. BMC Infect Dis 2007 1.31
14 Persistence of the immune response induced by BCG vaccination. BMC Infect Dis 2008 1.29
15 Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy. J Immunol 2005 1.24
16 BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi. J Infect Dis 2011 1.21
17 Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr Opin Infect Dis 2003 1.21
18 A comparison of IFNgamma detection methods used in tuberculosis vaccine trials. Tuberculosis (Edinb) 2008 1.21
19 Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining. BMC Immunol 2010 1.15
20 Biomarkers for TB treatment response: challenges and future strategies. J Infect 2008 1.14
21 Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults. Clin Diagn Lab Immunol 2003 1.11
22 Complex cytokine profiles induced by BCG vaccination in UK infants. Vaccine 2009 1.09
23 Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study. Trans R Soc Trop Med Hyg 2004 1.09
24 From genome-based in silico predictions to ex vivo verification of leprosy diagnosis. Clin Vaccine Immunol 2009 1.09
25 Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosy. Mem Inst Oswaldo Cruz 2012 1.08
26 CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis. PLoS One 2009 1.07
27 Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG. Clin Vaccine Immunol 2013 1.07
28 Differences between naive and memory T cell phenotype in Malawian and UK adolescents: a role for Cytomegalovirus? BMC Infect Dis 2008 1.05
29 Extended culture enhances sensitivity of a gamma interferon assay for latent Mycobacterium tuberculosis infection. Clin Vaccine Immunol 2007 1.04
30 New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy. J Immunol 2012 1.02
31 Immunogenicity of Danish-SSI 1331 BCG vaccine in the UK: comparison with Glaxo-Evans 1077 BCG vaccine. Vaccine 2006 1.00
32 Mycobacterial purified protein derivatives stimulate innate immunity: Malawians show enhanced tumor necrosis factor alpha, interleukin-1beta (IL-1beta), and IL-10 responses compared to those of adolescents in the United Kingdom. Infect Immun 2004 0.99
33 Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy. Clin Vaccine Immunol 2010 0.97
34 Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children. Clin Vaccine Immunol 2013 0.96
35 Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus. Immunol Rev 2015 0.96
36 Analysis of host responses to Mycobacterium tuberculosis antigens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan Africa. PLoS One 2013 0.94
37 The PPD-specific T-cell clonal response in UK and Malawian subjects following BCG vaccination: a new repertoire evolves over 12 months. Vaccine 2005 0.93
38 Differential gene expression identifies novel markers of CD4+ and CD8+ T cell activation following stimulation by Mycobacterium tuberculosis. J Immunol 2004 0.93
39 Long-lived memory B-cell responses following BCG vaccination. PLoS One 2012 0.92
40 Combination of cytokine responses indicative of latent TB and active TB in Malawian adults. PLoS One 2013 0.87
41 Recombinant ESAT-6-CFP10 Fusion Protein Induction of Th1/Th2 Cytokines and FoxP3 Expressing Treg Cells in Pulmonary TB. PLoS One 2013 0.85
42 A courageous step down the road toward a new tuberculosis vaccine. Am J Respir Crit Care Med 2009 0.85
43 Gamma delta T cell responses associated with the development of tuberculosis in health care workers. FEMS Immunol Med Microbiol 2005 0.84
44 [Increased IL-4 production in response to virulent Mycobacterium tuberculosis in tuberculosis patients with advanced disease]. Acta Med Port 2005 0.84
45 BCG vaccination: a role for vitamin D? PLoS One 2011 0.84
46 Factors affecting immunogenicity of BCG in infants, a study in Malawi, The Gambia and the UK. BMC Infect Dis 2014 0.83
47 Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents. Immunology 2004 0.83
48 Differences in T-cell responses between Mycobacterium tuberculosis and Mycobacterium africanum-infected patients. Eur J Immunol 2014 0.83
49 Comparison of IFN-gamma responses to mycobacterial antigens as markers of response to BCG vaccination. Tuberculosis (Edinb) 2008 0.82
50 The frequency of Chlamydia trachomatis major outer membrane protein-specific CD8+ T lymphocytes in active trachoma is associated with current ocular infection. Infect Immun 2006 0.81
51 Cytokine production and lymphocyte proliferation in patients with Nocardia brasiliensis actinomycetoma. Mycopathologia 2004 0.81
52 Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination. Eur J Immunol 2012 0.80
53 Strain-dependent variation in Mycobacterium bovis BCG-induced human T-cell activation and gamma interferon production in vitro. Infect Immun 2007 0.79
54 Variability between countries in cytokine responses to BCG vaccination: what impact might this have on protection? Expert Rev Vaccines 2012 0.79
55 The Current Status of BCG Vaccination in Young Children in South Korea. Tuberc Respir Dis (Seoul) 2012 0.78
56 Molecular methods for distinguishing between relapse and reinfection in leprosy. Trop Med Int Health 2008 0.77
57 Modulation of NKG2D expression in human CD8(+) T cells corresponding with tuberculosis drug cure. PLoS One 2013 0.77
58 Keep the faith--leprosy still needs new diagnostic tools and laboratory research. Lepr Rev 2011 0.76
59 Evaluation of cell-mediated immune responses to two BCG vaccination regimes in young children in South Korea. Vaccine 2011 0.76
60 Another step down the development pipeline for the novel tuberculosis vaccine MVA-85A. J Infect Dis 2011 0.75
61 A new challenge for the tuberculosis vaccine community? J Infect Dis 2012 0.75
62 Towards new TB vaccines: What are the challenges? Pathog Dis 2016 0.75
63 Global collaborations in leprosy research--the future is connected. Lepr Rev 2008 0.75
64 Real vaccines in the real world: tuberculosis vaccines move south. Expert Rev Vaccines 2008 0.75